IPA - Rega marang bathi mangsa ngarep immunoprecise.com
ImmunoPrecise Antibodies (IPA) is a recognized leader in AI-driven targeted antibody development trusted by the largest pharmaceutical behemoths. The company's forward P/E clearly captures market expectations, while the 47.10 metric confirms the current valuation level. This Canadian biotech is shielded from geopolitical risks by its medical status. An impeccable image as an innovative "discovery factory" is accelerating the global search for new drugs.
Ringkesan rincian data analitis ImmunoPrecise (IPA)
- nilai saham lan prakiraan konsensus rega:
- statistik kapitalisasi pasar:
- data ekuitas miturut neraca:
- data tingkat utang lan likuiditas finansial:
Total Utang marang Modal ImmunoPrecise Antibodies|IPA - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang modal ImmunoPrecise Antibodies|IPA - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku ImmunoPrecise Antibodies Ltd|IPA - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan ImmunoPrecise Antibodies|Rasio cepet immunoprecise.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
IPA - Penghasilan resik perusahaan|Bathi mangsa ngarep ImmunoPrecise Antibodies|IPA - Nilai perusahaan marang bathi resik|Pangali Forward P/E ImmunoPrecise Antibodies|IPA - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan ImmunoPrecise Antibodies Ltd|IPA - Bathi operasional sadurunge amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan ImmunoPrecise Antibodies|IPA - Bathi saben saham sajrone patang kuartal pungkasan|Wutah bathi EPS kuartalan immunoprecise.com|IPA - Prakiraan wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep ImmunoPrecise Antibodies
Analisis fundamental perusahaan:ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Antibodies (IPA) optimizes antibody discovery via AI platforms, reducing chemical waste and adhering to ESG ethical standards. By analyzing the company's projected P/E multiple valuation, an investor assesses the current share price relative to expected net income; however, ignoring the macroeconomic backdrop and relying solely on historical multiple peaks during a liquidity crunch could lead to substantial capital loss.
Pesaing utama
Rega marang bathi mangsa ngarep Tempus Labs (TEM)|Qiagen NV - Rasio rega marang bathi mangsa ngarep|Rega marang bathi mangsa ngarep Ionis Pharma IONS|Repligen Inc. (RGEN) - Rasio prakiraan rega marang bathi|RNA - Rega marang bathi mangsa ngarep|Rasio rega marang bathi sing dikarepake CRSP|GeneDx (WGS) - Rega marang bathi mangsa ngarep|Ultragenyx Pharmaceutical Inc. - Pangali mangsa ngarep rega marang bathi|BEAM (Beam Therapeutics Corp) - Pangali Forward P/E|Rasio prakiraan rega marang bathi Sarepta Corp SRPT|Pangali Forward P/E TWST|Prakiraan rega marang bathi 10xgenomics.com TXG|Pangali Forward P/E NTLA (Intellia Therapeutics, Inc.)|Kapitalisasi marang proyeksi bathi Stoke Therapeutics Inc (STOK)|BLFS - Rega marang bathi mangsa ngarep|Kapitalisasi marang proyeksi bathi Wave Pharma WVE|MAZE: Pangali Forward P/E|Rasio prakiraan rega marang bathi sionnatx.com (SION)|Prakiraan rega marang bathi PRME|TSHA: Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E QURE|Pangali Forward P/E MeiraGTx Corp (MGTX)|Rega marang bathi mangsa ngarep REGENXBIO Inc. RGNX|SLDB: Rasio rega marang bathi mangsa ngarep|OCGN: Prakiraan rega marang bathi|Pacific Biosciences of California, Inc. - Rasio kapitalisasi marang bathi mangsa ngarep|BNTC: Pangali Forward P/E|DSGN - Kapitalisasi marang proyeksi bathi|RCKT (Rocket Pharmaceuticals) - Pangali Forward P/E|Rega marang bathi mangsa ngarep FDMT|Rega marang bathi mangsa ngarep Lexeo Therapeutics (LXEO)|KRRO - Rasio prakiraan rega marang bathi|Pangali Forward P/E EDIT (Editas)|SLN: Rasio rega marang bathi mangsa ngarep|ProQR Therapeutics NV - Pangali Forward P/E|Kapitalisasi marang proyeksi bathi Codexis, Inc. CDXS|SGMO: Pangali Forward P/E|Rasio prakiraan rega marang bathi Nautilus Bio (NAUT)|Rega marang bathi mangsa ngarep Metagenomi, Inc|Precision BioSciences Inc. (DTIL) - Kapitalisasi marang proyeksi bathi|Pangali Forward P/E GBIO|Kapitalisasi marang proyeksi bathi boundlessbio.com|Rega marang bathi mangsa ngarep Exicure XCUR|IMNN (Imunon Inc) - Rasio rega marang bathi sing dikarepake|RXi Pharmaceuticals - Pangali Forward P/E|MBIO - Pangali Forward P/E|RNAZ: Pangali Forward P/E|Rasio rega marang bathi mangsa ngarep BNGO|Rega marang bathi mangsa ngarep Applied DNA Sciences, Inc.|Rasio rega marang bathi mangsa ngarep BLUE (bluebird bio Inc.)|Pangali Forward P/E OMGA|Pangali Forward P/E Singular Genomics Corp (OMIC)|Pangali Forward P/E RGLS (Regulus Therapeutics)|Kapitalisasi marang proyeksi bathi syros.com (SYRS)|TBIO - Rega marang bathi mangsa ngarep|TRACON Pharmaceuticals Inc. (TCON) - Prakiraan rega marang bathi|Unity Bio (UBX) - Rega marang bathi mangsa ngarep
